Description
Roger Pharma TIRZEVAC (Tirzepatide) is a peptide formulation containing Tirzepatide, a dual GLP-1 and GIP receptor agonist widely studied for its role in metabolic regulation, glucose homeostasis, appetite signaling, and body weight management. It is commonly researched for its potential applications in endocrinology and metabolic health.
Each pack contains 5 vials, with 5 mg of Tirzepatide per vial, providing a total peptide content of 25 mg. Roger Pharma TIRZEVAC is supplied in a lyophilized format and is intended for research applications involving peptide science, metabolic biology, and endocrine studies.
Key Features
- Tirzepatide peptide formulation
- 5 mg per vial
- 5 vials per pack
- Total peptide content: 25 mg
- Lyophilized peptide format
- Studied for GLP-1 and GIP receptor pathways
- Research-focused peptide compound
Contents
- Active Ingredient: Tirzepatide – 5 mg
- Quantity: 5 Vials
Reviews
There are no reviews yet.